Position in NERV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,357,755
New position
Shares Held
889,254
first reported quarter
Ownership
1.91%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026DV Trading LLC holds $140,728,709 across 15 Biotechnology names. NERV ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,439,393 | $97,418,118 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
300,648 | $6,289,556 | |
| 3 | AVTX |
Avalo Therapeutics, Inc.
|
360,064 | $5,375,755 | |
| 4 | NERV |
Minerva Neurosciences, Inc.
This page
|
889,254 | $5,357,755 | |
| 5 | PHVS |
Pharvaris N.V.
|
143,966 | $4,067,039 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
95,253 | $3,733,917 | |
| 7 | CTMX |
CytomX Therapeutics, Inc.
|
714,000 | $3,355,800 | |
| 8 | IPSC |
Century Therapeutics, Inc.
|
1,400,000 | $3,164,000 |
All Filings in NERV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,357,755 | 889,254 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||